Skip to content

Open nowFirst seen 37 hours ago

CEO OGYX (The Collider Programme)

Mobile World Capital5 open roles

Where
Barcelona, Spain, Remote
Work mode
Remote
Get the CV for this job

From $25 per CV, paid once. No subscription.

Your applicationOpen nowCEO OGYX (The Collider Programme)Mobile World Capital · Barcelona, Spain, Remote
  1. YouYes, apply to this one.

  2. CV RocketCV written for this posting.

  3. 25 readersRecruiter, hiring manager, skeptic. Round after round.

  4. CV RocketApplied on Mobile World Capital's own form.

The reply lands in your private mailbox

3×more interviews than doing it yourself with ChatGPT.

The clock on this job

Early applications get read.

11.8% of postings close within 7 days. Measured by our own scanner across the market.

Share of postings closed within
  1. 2.1%1 day
  2. 4.4%3 days
  3. 11.8%7 days
  4. 18.6%14 days
  5. 35.6%30 days
  6. 45.1%60 days
This job: first seen 37 hours ago

The posting

OGYX | High-Throughput Organ-on-a-Chip Platform

CEO & Co-Founder Opportunity | Deeptech BioEngineering | Drug Discovery

Are you looking for an entrepreneurial opportunity at the intersection of microfluidics, advanced in-vitro models and drug discovery, with the chance to build a high-impact deep-tech spin-off?

OGYX is developing a cost-effective, robust and user-friendly microfluidic Organ-on-a-Chip platform designed for high-throughput in-vitro assays in research, drug development and toxicology. Backed by Leitat and a strong technical team, the project is now seeking an entrepreneurial CEO to lead the creation of the spin-off and drive its commercial and strategic development.

As CEO & Co-Founder, you will lead the venture-building journey together with the scientific and technical team, shaping the business model, early market traction and fundraising strategy of a company with the potential to become a preferred platform provider in the Organ-on-a-Chip market.

About OGYX

Drug discovery still relies heavily on animal models and conventional in-vitro systems, both of which often fail to accurately replicate human physiology. This results in poor predictive power, major development inefficiencies and growing ethical and regulatory pressure to reduce animal testing.

Organ-on-a-Chip technologies offer a promising alternative, but current solutions face important limitations: they often compromise essential 2D/3D co-culture features, require peripheral equipment, or are not well suited for multiplexed high-throughput readouts and scalable production.

OGYX addresses this challenge with a microfluidic OoC plate designed for high-throughput screening, compatible with 2D/3D co-cultures and organoids, and readable with standard multi-well plate readers. Its design combines biological relevance, usability and manufacturability in a single platform.

Why OGYX

  • Novel Organ-on-a-Chip plate combining high-throughput screening with human-relevant 2D/3D co-culture capabilities
  • Patent published in 2024: WO2024033549
  • Technology designed for scalable production and ease of adoption
  • Gravity-driven microfluidics, avoiding peripheral flow equipment
  • Membrane-free design, reducing complexity and cost
  • Compatible with standard plate readers through a design-for-detection approach
  • Validated models already demonstrated in intestine, cartilage and tendon, with additional models under development including liver and kidney
  • Early industry validation and feedback through collaborations with Leitat and ReadyCell / MedTech Barcelona
  • The current microfluidic plate validation stage is TRL 7
  • Clear roadmap for spin-off creation, beta testing and commercial operation

Current Founding Team

  • Pooya Azizian – Future CTO
  • Joan Marc Cabot – Principal Investigator & Advisor Head of Diagnostic Devices Group

The project combines strong technical expertise in microfluidics and OoC systems with institutional backing and venture support from Leitat.

Your Role as CEO & Co-Founder (Next 6 Months)

You will lead OGYX through a critical transition phase focused on:

  • Spin-off creation and shareholder structuring
  • Defining the go-to-market strategy for CROs, biotech, pharma and research groups
  • Validating the business model and pricing logic across standard plates, customized plates and modelling services
  • Structuring early commercial traction and beta-testing strategy
  • Leading private fundraising efforts
  • Building partnerships with CROs, biotech companies and pharmaceutical players
  • Building engagement with regulatory agencies.
  • Supporting the strategic roadmap toward upscaling, product launch and new application development

The Offer

  • Relevant equity as CEO & Co-Founder upon company incorporation
  • €6,000 stipend during the validation phase (3 monthly instalments of €2,000)
  • Opportunity to access a participative loan of up to €50,000 to finance the first phases of the project
  • Access to The Collider venture-building programme, including:
  • Mentors and specialists in biotech, IP, go-to-market and fundraising
  • Support in spin-off creation and shareholder structuring
  • Access to experts in life sciences and industrial strategy
  • International exposure through The Collider ecosystem (4YFN, Mobile World Congress, corporate & investor networks)
  • Coworking space in Barcelona (Tech Barcelona – Pier 01)
  • Two years of post-incorporation venture-builder support, including in-kind services, community access and portfolio perks

This Opportunity Is for You If

  • You are an entrepreneur with experience in biotech, life sciences, deep tech or scientific instrumentation
  • Previous experience as founder or co-founder
  • Strong network in pharmaceutical sector
  • You understand the dynamics of drug discovery, CROs, pharma or advanced research tools
  • Experience in B2B sales, fundraising and strategic partnerships
  • Familiarity with platform business models and technology transfer is a strong plus
  • You are comfortable bridging science, product and business strategy
  • Eligible to work in Spain
  • Fluent in English and Spanish, Catalan is a plus.
From $25, paid onceGet the CV for this job

What happens when you press

One press. We do the rest.

  1. A CV for this posting

    Written against Mobile World Capital's own wording, from every piece of relevant proof in your profile.

  2. 25 readers review it

    Recruiter, hiring manager, skeptic and more read every draft, round after round. You get the best round.

    The review screen in CV Rocket: how each CV was read, round by round.
  3. We apply on Mobile World Capital's form

    Our application engine gets through the hardest forms there are. Where a question needs you, AI suggests the best answer. Don't want us applying from our IP addresses? Use our Chrome extension: we apply straight from your own browser.

    An application in CV Rocket: every answer filled in on the employer's form.
  4. Every reply, sorted

    Mobile World Capital's answer lands in your private mailbox, and we classify it on arrival: interview, question, rejection.

    The CV Rocket inbox: each employer reply classified as an interview, an action or a rejection.
  5. Reply with AI

    AI helps you write the email, checks it and sends it. We show you whether the recruiter read it.

  6. The interview in your calendar

    Full integration with your calendar. The invitation goes straight in.

    An interview invitation in the CV Rocket inbox, added to the candidate's calendar.
Get the CV for this job

From $25 per CV, paid once. No subscription.

Why it works

3×

more interviews than doing it yourself with ChatGPT.

ChatGPT writes a CV and never learns what happened to it. We see every reply. For each CV we know:

  • How it was written, and how the review scored it
  • When we applied, and how long after the posting went up
  • Which posting, which company, which city
  • Who got the interview, and who heard nothing

That is how we know which CVs get called.

Get the CV for this job

From $25 per CV, paid once. No subscription.

The numbers game

More applications. More interviews.

Every application goes out with its own CV, written for that posting and paid once. Send enough of them and the law of large numbers finds you the job.

By hand5–10
With CV Rocket100
applications a day

Before you press

Straight answers

Get the CV for this job

From $25 per CV, paid once. No subscription.

What if my background isn't good enough?

We make the most of the background you have. The CV uses every piece of relevant proof your profile holds, and one of the 25 readers reads your whole profile and flags what the CV left out.

Do you really apply for me?

Yes, on the employer's own form, the hardest ones included. Where a question needs you, you answer it right there and AI suggests the best answer. Don't want us applying from our IP addresses? Use our Chrome extension: we apply straight from your own browser.

Is it a subscription?

No. You pay once per CV, from $25. Every application goes out with its own CV, written for that posting.

One job. One CV.
Paid once.

Pick the posting you want. We write for it, apply for you and catch the reply.

Get the CV for this job

From $25 per CV, paid once. No subscription.